Quantamental Technologies LLC Allogene Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $129,898 - $235,272	-19,159 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $8,499 - $16,987	-1,111 Reduced 5.48%	19,159 $175,000
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $138,823 - $259,249	10,573 Added 109.03%	20,270 $302,000
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $31,872 - $41,929	-1,517 Reduced 13.53%	9,697 $249,000
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $263,416 - $401,461	11,214 New	11,214 $292,000

Q4 2019 Feb 14, 2020	SELL	$24.82 - $31.4 $7,446 - $9,420	-300 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$26.11 - $32.99 $7,833 - $9,897	300 New	300 $8,000

164

106M

97.5K

45.6K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $335M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.